Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial - CNBC

A potential coronavirus vaccine developed in China appeared to provoke neutralizing antibodies in dozens of patients in an early-stage clinical trial, an important step in developing a vaccine that might provide immunity to Covid-19. https://www.cnbc.com/2020/05/22/coronavirus-vaccine-in-china-produces-neutralizing-antibodies-in-early-stage-trial.html